NEW YORK, Sept. 28 /PRNewswire/ -- Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) announced that Justin P. Eggleton has joined as Director, Spine Regulatory Affairs. MCRA is a highly specialized, independently operated consulting firm serving the worldwide orthopedic industry.
He joins the firm from the U.S. Food and Drug Administration (FDA), where he was a lead reviewer in the Orthopedics Devices Branch for the Office of Device Evaluation.
Mr. Eggleton has an extensive knowledge of medical device regulations and regulatory pathways that drive orthopedic devices from conception to market acceptance. At the FDA, he led reviews of pre-market submissions in support of orthopedic Class II and Class III medical devices, including multiple leading Investigational Device Exemptions (IDE) and Pre-market Applications (PMA).
“I am excited to have joined an organization whose vision parallels my own in effectively bringing the most innovative spinal technologies to the U.S. and worldwide markets,” Mr. Eggleton said. “As a result, I can now couple my FDA experiences and knowledge with a passion for nurturing truly life-changing products.”
Mr. Eggleton led FDA reviews of several unique spinal implant technologies and received numerous performance awards. He received his Bachelor of Science degree in Biomedical Engineering from Drexel University, where he focused on biomaterials and tissue engineering and assisted in the development of novel nucleus replacement technologies.
Marc R. Viscogliosi, President of MCRA, said, “The spine market, especially in the non-fusion sector, is experiencing a tremendous amount of growth, leading many companies to pursue PMA’s. Justin’s experience in spine technologies will help companies to bring highly promising devices to the U.S. market, and ultimately help thousands of patients. We are delighted to have attracted a person with such excellent credentials to be part of the MCRA team.”
David W. Lown, General Manager of MCRA, said, “Justin is an accomplished professional, joining a growing team of specialized strategists who are able to realize MCRA’s vision of bringing outstanding client technologies more rapidly and efficiently to the U.S. marketplace.”
About MCRA, LLC
Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) is a highly specialized, independently operated consulting firm serving the worldwide orthopedic industry. MCRA is a group of leading strategists committed to executing regulatory, clinical, intellectual property (IP), and reimbursement strategies to move your company to successful value creation. Founded in 2003 by Viscogliosi Brothers, LLC, the firm provides “first-in-class” service to its clients through its superior knowledge base, global surgeon relationships and deeply experienced management team. MCRA places particular emphasis on working with companies at all stages of development, whether they are single- product companies or companies with multiple technologies. The true value of MCRA is the ability to cover the entire lifecycle of a product or technology by taking a product from the conceptual pre-clinical stage to market approval.
About Viscogliosi Brothers, LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, VB was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal /orthopedics sector of the health care industry. Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on “life changing” musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total of more than 35 years experience analyzing and investing in the musculoskeletal /orthopedics sector. They have pioneered innovative financial, strategic and management initiatives for companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
Contacts: Marc R. Viscogliosi William G. Armstrong, Jr. President The Dilenschneider Group (212) 583-0250 ext. 103 (212) 922-0900 mviscogliosi@mcrallc.comwarmstrong@dgi-nyc.com
Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA)
CONTACT: Marc R. Viscogliosi, President, +1-212-583-0250, ext. 103,mviscogliosi@mcrallc.com, or William G. Armstrong, Jr., The DilenschneiderGroup, +1-212-922-0900, warmstrong@dgi-nyc.com
Web site: http://www.mcrallc.com/
